Keita Sasaki

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes

Joji Nagasaki, Takashi Inozume, Nicolas Sax et al. · Cell Reports · 2022 · 114 citations · Full text

Life Sciences, Immunology, Oncology +14

Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury

Hitoshi Uchida, Keita Sasaki, Lin Ma et al. · Neuroscience · 2009 · 99 citations

Life Sciences, Genetics, Molecular Biology +17

The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma

Takashi Sugimoto, Naohiko Seki, Satoya Shimizu et al. · Genes Chromosomes and Cancer · 2008 · 67 citations

Life Sciences, Genetics, Molecular Genetics +12

Identification of a novel therapeutic target for head and neck squamous cell carcinomas: A role for the neurotensin‐neurotensin receptor 1 oncogenic signaling pathway

Satoya Shimizu, Jun Tsukada, Takashi Sugimoto et al. · International Journal of Cancer · 2008 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +14